- Report
- March 2025
- 200 Pages
Global
From €4195EUR$4,490USD£3,549GBP
- Report
- October 2024
- 270 Pages
China
From €3737EUR$4,000USD£3,161GBP
- Report
- August 2024
- 89 Pages
Global
From €3500EUR$4,013USD£3,065GBP
- Report
- October 2024
- 135 Pages
China
From €1682EUR$1,800USD£1,423GBP
Cephazolin is an antibiotic used to treat a variety of bacterial infections. It belongs to the cephalosporin class of antibiotics, which are derived from the fungus Acremonium. Cephazolin is used to treat infections caused by Gram-positive and Gram-negative bacteria, including skin and soft tissue infections, urinary tract infections, and respiratory tract infections. It is also used to prevent infections in certain surgical procedures. Cephazolin is available in both oral and injectable forms.
The cephazolin market is highly competitive, with a number of generic and branded products available. The market is driven by the increasing prevalence of bacterial infections, the rising demand for antibiotics, and the growing number of surgical procedures. The market is also influenced by factors such as the availability of generic drugs, the emergence of new antibiotics, and the increasing use of combination therapies.
Some of the major companies in the cephazolin market include Pfizer, Merck, Sanofi, Novartis, and GlaxoSmithKline. Show Less Read more